Literature DB >> 2914087

The versatile midforehead browlift.

T A Cook1, P J Brownrigg, T D Wang, V C Quatela.   

Abstract

Ptosis of the brow is a significant and often unrecognized portion of aging of the upper face. It contributes to both cosmetic and functional aging. Correction is often mandatory prior to blepharoplasty in that functional problems may be worsened without elevating the brow. Direct and coronal browlifts are the most common approach to the problem. Midforehead browlifts have been reserved for men with receding hairlines. We have, for the past three years, performed midforehead browlifts on all our patients needing ptotic brow correction. Our review of 72 patients treated in this way, including 52 women, shows excellent and long-lasting cosmetic and functional improvement. There have been few complications, and the resultant incisional scars have been very well accepted. Therefore, we feel that the midforehead browlift, performed as we describe, is the ideal surgical correction for the ptotic brow.

Entities:  

Mesh:

Year:  1989        PMID: 2914087     DOI: 10.1001/archotol.1989.01860260037011

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  The lateral brow: position in relation to age, gender, and ethnicity.

Authors:  Lora Rabin Dagi Glass; Jennifer Lira; Enkhnasan Enkhbold; Emmanuel Dimont; Stacy Scofield; Pamela R Sherwood; Bryan J Winn
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2014 Jul-Aug       Impact factor: 1.746

Review 2.  Aesthetic analysis of the ideal eyebrow shape and position.

Authors:  Esin Yalçınkaya; Cemal Cingi; Hakan Söken; Seçkin Ulusoy; Nuray Bayar Muluk
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-28       Impact factor: 2.503

3.  Determinative factors in surgical planning of eyebrow cosmetic and reconstructive surgery.

Authors:  Mohammad Taher Rajabi; Ali Makateb; Narges Hassanpoor; Seyedeh Simindokht Hosseini; Fatameh Bazvand; Syed Ziaeddin Tabatabaie; Mohammad Bagher Rajabi
Journal:  Clin Ophthalmol       Date:  2017-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.